How many studies have been conducted on Dihydroergocornine?

BiohacksAI has indexed 65 PubMed studies on Dihydroergocornine, including 2 randomized controlled trials (RCTs). 20% of studies involve human subjects.

What are the main research areas for Dihydroergocornine?

The primary research domains for Dihydroergocornine are ❤️ Cardiovascular, 🧠 Focus & Attention, 🧠 Cognitive. This is based on analysis of 65 PubMed studies using the BiohacksAI evidence platform.

Dihydroergocornine

A 9,10alpha-dihydro derivative of ERGOTAMINE that contains isopropyl sidechains at the 2' and 5' positions of the molecule.

65+ PubMed studies analyzed · 2 RCTs · Evidence Score: 43.8

Research Domains

Dihydroergocornine has been studied across 18 research domains including ❤️ Cardiovascular, 🧠 Focus & Attention, 🧠 Cognitive, 🌤️ Mood & Depression, 🫘 Kidney. The primary research focus is ❤️ Cardiovascular with 22% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Dihydroergocornine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Loading evidence profile...

This evidence profile for Dihydroergocornine is generated deterministically from 65 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.